Vaccitech Newsroom

Newsroom

News & updates

World-First NHS Trial For Universal Flu Vaccine

The world’s first widespread human testing of a flu vaccine which researchers hope will protect more over 65-year-olds against influenza has begun in the NHS. More than 2,000 people aged 65 and over will be asked to take part in a study supported by the National...

Vaccitech Launch RIVET Study

Vaccitech has engaged with Primary Care Clinical Trial Unit at Oxford University to run a small pilot study entitled RIVET (Re-inventing Influenza vaccine Efficacy Trials) as a precursor to its large phase IIb (INVICTUS) novel influenza vaccine study scheduled to...

Vaccitech Feature in Jenner Institute Autumn 2016 Newsletter

Vaccitech: Spin out kick starts with £10m from Oxford Sciences Innovation Oxford spin out company Vaccitech was launched in May 2016 with a £10m investment from Oxford Sciences Innovation to take a number of vaccines through clinical trials. The company’s most...

OBN Awards 2016: Vaccitech Announced as Finalists

Finalists Announced for OBN Awards 2016 OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies has announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health. The OBN Awards...

Dr Steve Chatfield Joins Vaccitech

Vaccitech are delighted to welcome Dr Steve Chatfield following his appointment as a Non-Executive Director with the Company. Steve has worked for more than 35 years in the Biopharmaceutical Industry and the public sector developing and commercialising public health...